By: Frank Angst Thoroughbred Horsemen's Association chairman Alan Foreman is confident a 2015 decision by a Delaware assistant attorney general not to pursue a medication overage case against trainer Todd Pletcher will not negatively impact the National Uniform Medication Program. Speaking at the Association of Racing Commissioners conference March 24, Foreman said he doesn't expect
RMTC By Tom LaMarra An effort that began in the Mid-Atlantic region more than two years ago has made "significant progress," according to the Racing Medication and Testing Consortium. Adoption of the National Uniform Medication Program hasn't been without its twists and turns, but given the fractured nature of the Thoroughbred industry and the need
by Frank Vespe Calling the law and regulations which govern Maryland racing “very antiquated,” Maryland Racing Commission chairman Bruce Quade today announced a top-to-bottom review of the state’s racing law. And if he has his way, that review may lead to swifter justice meted out to jockeys with riding violations and harsher penalties for trainers
NEWS RELEASE July 19, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC GIVES FINAL APPROVAL FOR MULTIPLE VIOLATION PENALTY MODEL RULE The Racing Medication and Testing Consortium (RMTC) board of directors has given final approval for a Multiple Violation Penalty (MVP) model rule and has forwarded it to the Association of Racing Commissioners International (RCI)
NEWS RELEASE March 21, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD RECOMMENDS THERAPEUTIC WITHDRAWAL TIMES, GRANTS FIRST INTERIM LAB ACCREDITATION At its March 19 meeting in Baltimore, Maryland, the Racing Medication and Testing Consortium (RMTC) board of directors adopted recommendations for thresholds and withdrawal times for four therapeutic medications identified by the Association
NEWS RELEASE October 10, 2011 Contact: Hallie Lewis (859) 224-2848 or Chris Scherf (410) 392-9200 RACE DAY MEDICATION, DRUG TESTING INITIATIVES AND RESEARCH COMMITTEES PROVIDE UPDATES TO RMTC BOARD At its October 6 meeting in Scottsdale, Arizona, the Racing Medication and Testing Consortium (RMTC) board of directors heard important updates from the race day medication,
NEWS RELEASE August 4, 2011 Contact: Hallie Lewis (859) 224-2848 or Chris Scherf (302) 981-6145 RMTC APPROVES NEW POLICY RECOMMENDATIONS BASED ON REPORTS FROM ITS RACE DAY MEDICATION COMMITTEES HEBRON, KY --The Racing Medication and Testing Consortium (RMTC) board of directors voted today to support a requirement that furosemide only be administered on race day
NEWS RELEASE October 20, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC MAKES THERAPEUTIC WITHDRAWAL TIME RECOMMENDATIONS, ANNOUNCES PROGRESS OF ITS DRUG TESTING INITIATIVES TASK FORCE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has recommended scientifically identified withdrawal guidelines and plasma thresholds for the
NEWS RELEASE May 7, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC TO FUND POST-DOCTORAL RESEARCH FELLOWSHIP FOR TWO APPLICANTS The Racing Medication and Testing Consortium (RMTC) board of directors has approved the funding of Dr. Heather DiMaio Knych and Dr. Mary Robinson for its post-doctoral research fellowship program. This commitment fulfills one of the main
NEWS RELEASE April 15, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC RECOMMENDS NEW PHENYLBUTAZONE THRESHOLD LEVEL, ANNOUNCES LAUNCH OF RECENT RULINGS DATABASE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has revised its recommended threshold for the non-steroidal anti-inflammatory drug (NSAID) phenylbutazone from 5
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
